Fluoroquinolonas para el tratamiento de la fiebre tifoidea y paratifoidea (fiebre entérica)
Información
- DOI:
- https://doi.org/10.1002/14651858.CD004530.pub4Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 05 octubre 2011see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Enfermedades infecciosas
- Clasificada:
-
- Actualización no planificada
Other
An updated search (5 Sep, 2016) identified 4 studies for inclusion ('Studies awaiting classification’ section: Ali 2011; Arjyal 2016; Chandey 2012; Koirala 2013). In an external analysis for the WHO, inclusion of these 4 studies did not change the 2011 published version's results. The WHO used these results in 2017 (unpublished report for the WHO SAGE Typhoid Working Group, 2017).Evaluada: 8 May 2019
- Actualización no planificada
- Copyright:
-
- Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Emmanuel Effa and Zohra Lassi , considered the new search, extracted and enter data, updated the risk of bias assessment and Dave Sinclair co‐extracted data, assisted with restructuring and writing up of the review. Julia Critchley provided technical inputs and assisted with the restructuring of the review. Prof Zulfiquar Bhutta, Prof Paul Garner, and Piero Olliaro guided the restructuring, examined the data, provided technical direction and edited the manuscript. All authors contributed to the final manuscript.
Sources of support
Internal sources
-
University of Calabar Teaching Hospital, Calabar, Nigeria.
-
Nigeria branch of South African Cochrane centre, Nigeria.
External sources
-
No sources of support supplied
Declarations of interest
None known. Professor ZA Bhutta has been part of trials of treatment for typhoid therapy in children, none of which involved fluoroquinolones.
Acknowledgements
Emmanuel Effa's fellowship to Liverpool School of Tropical Medicine, and the update of this review was supported by a grant from the World Health Organization. The Cochrane Infectious Diseases Group is funded by the UK Department for International Development (DFID) for the benefit of low‐ and middle‐countries.
We acknowledge Vittoria Lutje, Trials Search Co‐ordinator for the CIDG for assistance with the searches as well as staff of the CIDG for assistance during the process of updating the review.
The Contact Editor for this review was Dr Mical Paul.
Thanks to Durrane Thaver, who wrote the original and first update of this review. She is fondly remembered by all of us that knew her.
Version history
| Published | Title | Stage | Authors | Version |
| 2011 Oct 05 | Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) | Review | Emmanuel E Effa, Zohra S Lassi, Julia A Critchley, Paul Garner, David Sinclair, Piero L Olliaro, Zulfiqar A Bhutta | |
| 2008 Oct 08 | Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) | Review | Durrane Thaver, Anita KM Zaidi, Julia A Critchley, Asma Azmatullah, Syed Ali Madni, Zulfiqar A Bhutta | |
| 2005 Apr 20 | Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) | Review | Durrane Z Thaver, Anita KM Zaidi, Julia A Critchley, S A Madni, Zulfiqar A Bhutta | |
| 2003 Oct 20 | Fluoroquinolones for treating enteric fever | Protocol | Durrane Z Thaver, Anita KM Zaidi, Julia Critchley, Zulfiquar A Bhutta | |
Differences between protocol and review
We changed the intervention from 'Fluoroquinolone antibiotic' to 'Different fluoroquinolone antibiotic excluding norfloxacin or other fluoroquinolones not currently in use'
Notes
The Contact Editor for this review was Dr Mical Paul.
